Register

SmallMolecules.com > Supplier: LKT Laboratories, Inc.

LKT Laboratories, Inc.

LKT Laboratories, Inc. is a research and development company focused on the discovery of specialty chemicals for cancer chemoprevention. We produce and distribute unique chemicals and biochemicals for all types of life science research and supply raw materials for manufacturing and repacking.

Company Website

Product Listing

Triacetyl Aloe-emodin (Impurity A) 10 mg | ≥98%

LKT Laboratories, Inc.

Derivative of aloe-emodin, anthraquinone found in aloe; CFTR Cl- channel activator.

More Information Supplier Page

Triacetyl Aloe-emodin (Impurity A) 25 mg | ≥98%

LKT Laboratories, Inc.

Derivative of aloe-emodin, anthraquinone found in aloe; CFTR Cl- channel activator.

More Information Supplier Page

Triacetyl Aloe-emodin (Impurity A) 100 mg | ≥98%

LKT Laboratories, Inc.

Derivative of aloe-emodin, anthraquinone found in aloe; CFTR Cl- channel activator.

More Information Supplier Page

Triacetyl Resveratrol 10 mg | ≥98%

LKT Laboratories, Inc.

Resveratrol prodrug; potential SIRT1 activator.

More Information Supplier Page

Triacetyl Resveratrol 25 mg | ≥98%

LKT Laboratories, Inc.

Resveratrol prodrug; potential SIRT1 activator.

More Information Supplier Page

Triacetyl Resveratrol 100 mg | ≥98%

LKT Laboratories, Inc.

Resveratrol prodrug; potential SIRT1 activator.

More Information Supplier Page

Triacsin C 1 mg | ≥95%

LKT Laboratories, Inc.

Acyl-CoA synthetase inhibitor.

More Information Supplier Page

Triacsin C 5 mg | ≥95%

LKT Laboratories, Inc.

Acyl-CoA synthetase inhibitor.

More Information Supplier Page

Triadimefon 5 g | ≥98%

LKT Laboratories, Inc.

Neurotoxin, mutagen.

More Information Supplier Page

Triadimefon 10 g | ≥98%

LKT Laboratories, Inc.

Neurotoxin, mutagen.

More Information Supplier Page

Triadimefon 25 g | ≥98%

LKT Laboratories, Inc.

Neurotoxin, mutagen.

More Information Supplier Page

Triadimenol 10 g | ≥96%

LKT Laboratories, Inc.

Triadimefon metabolite; mutagen.

More Information Supplier Page

Triadimenol 25 g | ≥96%

LKT Laboratories, Inc.

Triadimefon metabolite; mutagen.

More Information Supplier Page

Triadimenol 100 g | ≥96%

LKT Laboratories, Inc.

Triadimefon metabolite; mutagen.

More Information Supplier Page

Triamcinolone 50 mg | ≥98%

LKT Laboratories, Inc.

Synthetic steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone 250 mg | ≥98%

LKT Laboratories, Inc.

Synthetic steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone 1 g | ≥98%

LKT Laboratories, Inc.

Synthetic steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone 5 g | ≥98%

LKT Laboratories, Inc.

Synthetic steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone Acetonide 50 mg | ≥98%

LKT Laboratories, Inc.

Synthetic steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone Acetonide 250 mg | ≥98%

LKT Laboratories, Inc.

Synthetic steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone Acetonide 1 g | ≥98%

LKT Laboratories, Inc.

Synthetic steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone Acetonide 5 g | ≥98%

LKT Laboratories, Inc.

Synthetic steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone Acetonide Acetate 50 mg | ≥97%

LKT Laboratories, Inc.

Steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone Acetonide Acetate 250 mg | ≥97%

LKT Laboratories, Inc.

Steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone Acetonide Acetate 1 g | ≥97%

LKT Laboratories, Inc.

Steroid; glucocorticoid agonist.

More Information Supplier Page

Triamcinolone Acetonide Acetate 5 g | ≥97%

LKT Laboratories, Inc.

Steroid; glucocorticoid agonist.

More Information Supplier Page

Trichostatin A 1 mg | ≥98%

LKT Laboratories, Inc.

HDAC inhibitor, mammalian RNA splicing modulator.

More Information Supplier Page

Trichostatin A 5 mg | ≥98%

LKT Laboratories, Inc.

HDAC inhibitor, mammalian RNA splicing modulator.

More Information Supplier Page

Triclosan 500 mg | ≥98%

LKT Laboratories, Inc.

Diarylether; bacterial ENR binder, fatty acid synthesis inhibitor.

More Information Supplier Page

Triclosan 5 g | ≥98%

LKT Laboratories, Inc.

Diarylether; bacterial ENR binder, fatty acid synthesis inhibitor.

More Information Supplier Page

Triclosan 25 g | ≥98%

LKT Laboratories, Inc.

Diarylether; bacterial ENR binder, fatty acid synthesis inhibitor.

More Information Supplier Page

Triclosan Methyl Ether 25 mg | ≥99%

LKT Laboratories, Inc.

Diarylether; bacterial ENR binder, fatty acid synthesis inhibitor.

More Information Supplier Page

Triclosan Methyl Ether 50 mg | ≥99%

LKT Laboratories, Inc.

Diarylether; bacterial ENR binder, fatty acid synthesis inhibitor.

More Information Supplier Page

Triflumizole 5 g | ≥95%

LKT Laboratories, Inc.

Imidazole; PPARγ agonist, RORγ inverse agonist, 14-α demethylase and aromatase inhibitor, ubiquitin/proteasome modulator.

More Information Supplier Page

Triflumizole 10 g | ≥95%

LKT Laboratories, Inc.

Imidazole; PPARγ agonist, RORγ inverse agonist, 14-α demethylase and aromatase inhibitor, ubiquitin/proteasome modulator.

More Information Supplier Page

Triflumizole 100 g | ≥95%

LKT Laboratories, Inc.

Imidazole; PPARγ agonist, RORγ inverse agonist, 14-α demethylase and aromatase inhibitor, ubiquitin/proteasome modulator.

More Information Supplier Page

Triflumuron 10 g | ≥98%

LKT Laboratories, Inc.

Insect growth regulator; chitin synthesis inhibitor.

More Information Supplier Page

Triflumuron 25 g | ≥98%

LKT Laboratories, Inc.

Insect growth regulator; chitin synthesis inhibitor.

More Information Supplier Page

Triflumuron 100 g | ≥98%

LKT Laboratories, Inc.

Insect growth regulator; chitin synthesis inhibitor.

More Information Supplier Page

Trifluoperazine Dihydrochloride 5 g | ≥98%

LKT Laboratories, Inc.

Phenothiazine; D1/2 and α1-adrenergic antagonist, calmodulin and CDPK4 inhibitor, Nav1.4 and Nav1.7 Na+ channel blocker.

More Information Supplier Page

Trifluoperazine Dihydrochloride 10 g | ≥98%

LKT Laboratories, Inc.

Phenothiazine; D1/2 and α1-adrenergic antagonist, calmodulin and CDPK4 inhibitor, Nav1.4 and Nav1.7 Na+ channel blocker.

More Information Supplier Page

Trifluoperazine Dihydrochloride 25 g | ≥98%

LKT Laboratories, Inc.

Phenothiazine; D1/2 and α1-adrenergic antagonist, calmodulin and CDPK4 inhibitor, Nav1.4 and Nav1.7 Na+ channel blocker.

More Information Supplier Page

Trimebutine Base 10 g | ≥97%

LKT Laboratories, Inc.

BK K+ channel and L-type Ca2+ channel blocker.

More Information Supplier Page

Trimebutine Base 50 g | ≥97%

LKT Laboratories, Inc.

BK K+ channel and L-type Ca2+ channel blocker.

More Information Supplier Page

Trimebutine Maleate 1 g | ≥96%

LKT Laboratories, Inc.

L-type Ca2+ channel blocker, BK K+ channel modulator, potential opioid agonist.

More Information Supplier Page

Trimebutine Maleate 5 g | ≥96%

LKT Laboratories, Inc.

L-type Ca2+ channel blocker, BK K+ channel modulator, potential opioid agonist.

More Information Supplier Page

Trimetazidine 250 mg | ≥98%

LKT Laboratories, Inc.

Long-chain 3-ketoacyl-CoA thiolase inhibitor, potential kainate and AMPA antagonist.

More Information Supplier Page

Trimetazidine 1 g | ≥98%

LKT Laboratories, Inc.

Long-chain 3-ketoacyl-CoA thiolase inhibitor, potential kainate and AMPA antagonist.

More Information Supplier Page

Trimetazidine 5 g | ≥98%

LKT Laboratories, Inc.

Long-chain 3-ketoacyl-CoA thiolase inhibitor, potential kainate and AMPA antagonist.

More Information Supplier Page

Trimethoprim 5 g | ≥98%

LKT Laboratories, Inc.

Dihydrofolate reductase inhibitor.

More Information Supplier Page